Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HEMO ORGANIC vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 HEMO ORGANIC   ACTAVIS
EQUITY SHARE DATA
    HEMO ORGANIC
Mar-23
ACTAVIS
Dec-18
HEMO ORGANIC/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs7916,159-   
Low Rs710,840-   
Sales per share (Unadj.) Rs03,963.8-  
Earnings per share (Unadj.) Rs-0.2-1,276.8-  
Cash flow per share (Unadj.) Rs-0.2417.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-0.116,349.0-  
Shares outstanding (eoy) m3.47332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3,122.23.4 91,677.7%   
Avg P/E ratio x-270.9-10.6 2,561.9%  
P/CF ratio (eoy) x-270.932.3 -838.2%  
Price / Book Value ratio x-289.40.8 -35,046.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1484,489,898 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m00-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m01,318,372 0.0%  
Other income Rs m025,212 0.0%   
Total revenues Rs m01,343,584 0.0%   
Gross profit Rs m-134,548 -0.0%  
Depreciation Rs m0563,576 0.0%   
Interest Rs m076,078 0.0%   
Profit before tax Rs m-1-579,893 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m0-7,349 -0.0%   
Profit after tax Rs m-1-424,648 0.0%  
Gross profit margin %-1,092.02.6 -41,671.3%  
Effective tax rate %01.3 -0.0%   
Net profit margin %-1,093.4-32.2 3,394.6%  
BALANCE SHEET DATA
Current assets Rs m2540,727 0.0%   
Current liabilities Rs m4478,345 0.0%   
Net working cap to sales %-3,172.04.7 -67,036.6%  
Current ratio x0.61.1 49.6%  
Inventory Days Days020 0.0%  
Debtors Days Days4,319,62966 6,514,394.4%  
Net fixed assets Rs m0149,232 0.0%   
Share capital Rs m350-   
"Free" reserves Rs m-350-   
Net worth Rs m-15,437,670 -0.0%   
Long term debt Rs m01,914,801 0.0%   
Total assets Rs m28,500,316 0.0%  
Interest coverage x0-6.6-  
Debt to equity ratio x-0.70.4 -194.9%  
Sales to assets ratio x00.2 15.8%   
Return on assets %-26.8-4.1 652.7%  
Return on equity %107.2-7.8 -1,372.7%  
Return on capital %341.3-4.8 -7,049.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1471,005 0.0%  
From Investments Rs mNA258,756 0.0%  
From Financial Activity Rs mNA-808,385 -0.0%  
Net Cashflow Rs m1-78,232 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare HEMO ORGANIC With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare HEMO ORGANIC With: DIVIS LABORATORIES  AARTI PHARMALABS  UNJHA FORMUL  BANDARAM PHARMA PACKTECH  HIKAL.  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.